Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024;53(8):641-649.
doi: 10.1159/000539808. Epub 2024 Jun 13.

Tachycardia and Acute Kidney Injury among Critically Ill Patients with Sepsis: A Prospective Observational Study

Affiliations
Observational Study

Tachycardia and Acute Kidney Injury among Critically Ill Patients with Sepsis: A Prospective Observational Study

Naoki Hayase et al. Blood Purif. 2024.

Abstract

Introduction: Tachycardia caused by sympathetic overactivity impairs myocardial function and raises septic patients' mortality. This study examined whether tachycardia is associated with acute kidney injury (AKI) period-prevalence among critically ill patients with and without sepsis.

Methods: In 328 patients (119 sepsis and 209 non-sepsis) admitted to our intensive care unit (ICU), we assessed heart rate at ICU admission, plasma neutrophil gelatinase-associated lipocalin (NGAL) and N-terminal pro-B-type natriuretic peptide, and urinary L-type fatty acid-binding protein and N-acetyl-β-<sc>d</sc>-glucosaminidase (NAG) at 0 and 48 h after admission. Tachycardia was defined as a heart rate above 100 beats/min.

Results: Tachycardia was independently correlated with AKI prevalence during the first week after ICU admission in the septic patients, but not in the non-septic patients. A dose-dependent increase in AKI period-prevalence was observed across ascending heart rate ranges. Furthermore, we discovered a dose-dependent increase in renal biomarker-positive patients regarding plasma NGAL and urinary NAG over increasing heart rate ranges 48 h after admission.

Conclusion: The findings revealed an independent relationship between tachycardia and AKI prevalence during the first week of ICU in septic patients. Heart rate was found to have a dose-dependent effect on AKI prevalence and renal insult monitored by biomarkers.

Keywords: Acute kidney injury; Biomarker; Sepsis; Tachycardia.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1.
Fig. 1.
Study flow diagram. ESRD, end-stage renal disease.
Fig. 2.
Fig. 2.
The prevalence of AKI within a week according to ascending ranges of heart rate at ICU admission among the septic patients. #p < 0.05 versus the reference range of 40–80 beats/min by χ2 test or Fisher’s exact test with Bonferroni post hoc test. AKI, acute kidney injury; ICU, intensive care unit.
Fig. 3.
Fig. 3.
Cardiorenal biomarkers across increasing heart rate ranges in the septic patients with complete data of the biomarkers.#p < 0.05 versus the reference range of 40–80 beats/min by χ2 test or Fisher’s exact test with Bonferroni post hoc test. L-FABP, L-type fatty acid-binding protein; NAG, N-acetyl-b-d-glucosaminidase; NGAL, neutrophil gelatinase-associated lipocalin; NT-proBNP, N-terminal pro-B-type natriuretic peptide.

Similar articles

Cited by

References

    1. Magder SA. The ups and downs of heart rate. Crit Care Med. 2012;40(1):239–45. - PubMed
    1. Selby DE, Palmer BM, LeWinter MM, Meyer M. Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction. J Am Coll Cardiol. 2011;58(2):147–54. - PMC - PubMed
    1. Hayase N, Yamamoto M, Asada T, Isshiki R, Yahagi N, Doi K. Association of heart rate with N-terminal pro-B-type natriuretic peptide in septic patients: a prospective observational cohort study. Shock. 2016;46(6):642–8. - PubMed
    1. Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, et al. . Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013;310(16):1683–91. - PubMed
    1. Kakihana Y, Nishida O, Taniguchi T, Okajima M, Morimatsu H, Ogura H, et al. . Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial. Lancet Respir Med. 2020;8(9):863–72. - PubMed

Publication types

MeSH terms